TheStreet

Log In

Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.
Forgot your password?Don't have an account? Sign Up Here

Join Us

Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.
Already have an account? Login here
TheStreet
JIM CRAMERINVESTINGPERSONAL FINANCERETIREMENTTECHNOLOGYMARKETSHOW-TOVIDEOFINANCIAL ADVISOR CENTER
Search

Trade with Jim Cramer 14 Days Free

Join the Action Alerts PLUS Community today!

SUBSCRIBE NOW
PRESS RELEASES

Wize Pharma's Strategic Transaction Partner Bonus BioGroup Reports Successful Treatment Of Acute Pneumonia In Preclinical COVID-19 Model

  • By PR Newswire
  • May 18, 2020 9:00 AM EDT
PRESS RELEASES

Wize Pharma Completes Phase IV Study Of LO2A For The Treatment Of Dry Eye Syndrome In Patients With Sjögren's Syndrome

  • By PR Newswire
  • May 7, 2020 9:00 AM EDT
PRESS RELEASES

Wize Pharma's Strategic Transaction Partner Bonus Biogroup Initiates Preclinical Study For Treatment Of Respiratory Distress In COVID-19 Patients

  • By PR Newswire
  • Apr 21, 2020 9:00 AM EDT
PRESS RELEASES

Wize Pharma Completes Bonus BioGroup Strategic Transaction

  • By PR Newswire
  • Feb 20, 2020 9:34 AM EST
PRESS RELEASES

Wize Pharma Completes Patient Enrollment In Phase IV Study Of LO2A For The Treatment Of Dry Eye Syndrome In Patients With Sjögren's Syndrome

  • By PR Newswire
  • Jan 21, 2020 9:00 AM EST
PRESS RELEASES

Wize Pharma Executes Agreements For Strategic Transaction With Bonus BioGroup

  • By PR Newswire
  • Jan 16, 2020 9:00 AM EST
TheStreet
  • Terms Of Use
  • Privacy Policy
  • Advertise
  • Reprints
  • Customer Service
  • Data
  • Topic Archive
  • Subscriptions
© 2021 TheStreet, Inc. All rights reserved. Action Alerts PLUS is a registered trademark of TheStreet, Inc.